Home/Filings/4/0000950170-24-003440
4//SEC Filing

Prout Samantha 4

Accession 0000950170-24-003440

CIK 0001178879other

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 6:07 PM ET

Size

6.7 KB

Accession

0000950170-24-003440

Insider Transaction Report

Form 4
Period: 2024-01-08
Prout Samantha
Chief Accounting Officer
Transactions
  • Sale

    Common Stock

    2024-01-09$14.00/sh1,337$18,71880,953 total
  • Sale

    Common Stock

    2024-01-08$14.00/sh30,767$430,82782,290 total
Footnotes (1)
  • [F1]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.00 to $14.03 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file

Issuer

AMICUS THERAPEUTICS, INC.

CIK 0001178879

Entity typeother

Related Parties

1
  • filerCIK 0001743122

Filing Metadata

Form type
4
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 6:07 PM ET
Size
6.7 KB